X-group (possible homology)

268 Sterol carrier protein-like

Ligands and drugs

663
Member domains
142
with ligand contacts (≤ 4 Å)
21.4% of members
150
with DrugDomain annotations
22.6% of members
83
with a DrugBank compound
12.5% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

22
Proteins with classified ligands
8
Superclasses bound (of 23)
7.9
Superclasses per 20 proteins
broader than 54% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds710.70.66×q = 0.19
Nucleosides, nucleotides, and analogues06.00q = 3.1e-3
Lipids and lipid-like molecules132.45.38×not tested
Organic nitrogen compounds10.71.45×not tested
Organic oxygen compounds64.31.39×not tested
Benzenoids21.61.26×not tested
Homogeneous non-metal compounds34.70.64×not tested
Organoheterocyclic compounds23.30.60×not tested
Organic acids and derivatives23.40.60×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB03796PLMPalmitic Acid11
DB01421PARParomomycin6
DB02080TRT1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene3
DB00684TOYTobramycin2
DB03047EPHL-Alpha-Phosphatidyl-Beta-Oleoyl-Gamma-Palmitoyl-Phosphatidylethanolamine2
DB00450USSDroperidol1
DB00502GMJHaloperidol1
DB00608CLQChloroquine1
DB00878XC9Chlorhexidine1
DB01131XEWProguanil1
DB02736ACMAcetamide1
DB03192—(R)-3-hydroxydecanoyl-CoA1
DB05636YMZ(+)-Mefloquine1
DB068941DO1-Dodecanol1

Most frequently bound compounds

PDB ligandNameDomains in contact
CLCHLORIDE ION16
NAmetalSODIUM ION14
PLMPALMITIC ACID11
CAmetalCALCIUM ION8
PARPAROMOMYCIN6
MGmetalMAGNESIUM ION5
P4Kpolyethylene glycol5
ZTP(2Z,6Z,10Z,14Z,18Z,22Z,26Z)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl trihydrogen diphosphate4
CUmetalCOPPER (II) ION3
OXNOXTOXYNOL-103
TRTFRAGMENT OF TRITON X-1003
E8Q2-azanylethyl-[(2~{S})-2,3-di(hexadecanoyloxy)propoxy]phosphinic acid2
EPHL-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL-PHOSPHATIDYLETHANOLAMINE2
LMR(2S)-2-hydroxybutanedioic acid2
MVIMycinamicin VI2
TBmetalTERBIUM(III) ION2
TOYTOBRAMYCIN2
0K3(2Z,6Z,10Z,14Z,18Z,22Z,26Z)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl dihydrogen phosphate1
5LQ5-(3-chlorophenyl)-4-methyl-~{N}-(3-morpholin-4-ylpropyl)-1,1-bis(oxidanylidene)-1,2-thiazol-3-amine1
5LR5-(4-chlorophenyl)-~{N}-[3-(3,4-dihydro-1~{H}-isoquinolin-2-yl)propyl]-4-methyl-1,1-bis(oxidanylidene)-1,2-thiazol-3-amine1